ePublished: 22 Aug 2015
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Nephropharmacol. 2016;5(1): 57-60.
  Abstract View: 9512
  PDF Download: 5811


Prevention of cisplatin nephrotoxicity

Fatemeh Hayati 1, Mehran Hossainzadeh 1, Shokouh Shayanpour 1, Zahra Abedi-Gheshlaghi 2, Seyed Seifollah Beladi Mousavi 1*

1 Chronic Renal Failure Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Nickan Research Institute, Isfahan, Iran
*Corresponding Author: *Corresponding author: Seyed Seifollah Beladi Mousavi, , Email: Beladimusavi@yahoo.com


Cisplatin has a well-established role in the treatment of broad spectrum of malignancies; however its use is limited because of cisplatin-induced nephrotoxicity (CIN) which can be progressive in more than 50% of cases. The most important risk factors for CIN include higher doses of cisplatin, previous cisplatin chemotherapy, underlying kidney damage and concurrent treatment with other potential nephrotoxin agents, such as aminoglycosides, nonsteroidal anti-inflammatory agents, or iodinated contrast media. Different strategies have been offered to diminish or prevent nephrotoxicity of cisplatin. The standard approach for prevention of CIN is the administration of lower doses of cisplatin in combination with full intravenous hydration prior and after cisplatin administration. Cisplatin-induced oxidative stress in the kidney may be prevented by natural antioxidant compounds. The results of this review show that many strategies for prevention of CIN exist, however, attention to the administration of these agent for CIN is necessary.

Implication for health policy/practice/research/medical education:

Cisplatin is important chemotherapeutic agents used to treat solid tumors, including head, ovarian and neck, and testicular germ cell tumors, which its use is limited because of cisplatin-induced nephrotoxicity (CIN) that can be progressive in significant percent of patients. In the early trials prior to the use of preventive measures, the amount of acute renal failure (ARF) incidence resulting from this drug was observed in more than 5o% of cases. It is recommended that preventive measures must be used in all patients treated with cisplatin and aim of this mini-review is evaluation of these preventive measures.

Please cite this paper as: Hayati F, Hossainzadeh M, Shayanpour S, Abedi-Gheshlaghi Z, Beladi Mousavi SS. Prevention of cisplatin nephrotoxicity. J Nephropharmacol. 2016;5(1):57-60.

First Name
Last Name
Email Address
Security code

Abstract View: 9513

Your browser does not support the canvas element.

PDF Download: 5811

Your browser does not support the canvas element.